Morgan Stanley lowered the firm’s price target on Nice (NICE) to $193 from $202 and keeps an Overweight rating on the shares. Q2 results were “largely in-line,” says the analyst, who continues to view the current valuation as “overly punitive on AI disruption risk.” The firm sees a favorable set-up into the capital markets day planned for October, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NICE: